Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 969 entries
Sorted by: Best Match Show Resources per page
[Questions and answers on rehabilitation. 2. Definition of the "acceptance of disability"].

Kangogaku zasshi

Gishima H, Kondo M, Shibuya Y, Hoshikawa N.
PMID: 6234418
Kangogaku Zasshi. 1984 May;48(5):577-80.

No abstract available.

Cite
Gishima H, Kondo M, Shibuya Y, et al. [Questions and answers on rehabilitation. 2. Definition of the "acceptance of disability"]. Kangogaku Zasshi. 1984;48(5):577-80
Gishima, H., Kondo, M., Shibuya, Y., & Hoshikawa, N. (1984). [Questions and answers on rehabilitation. 2. Definition of the "acceptance of disability"]. Kangogaku zasshi, 48(5), 577-80.
Gishima, H, et al. "[Questions and answers on rehabilitation. 2. Definition of the "acceptance of disability"]." Kangogaku zasshi vol. 48,5 (1984): 577-80.
Gishima H, Kondo M, Shibuya Y, Hoshikawa N. [Questions and answers on rehabilitation. 2. Definition of the "acceptance of disability"]. Kangogaku Zasshi. 1984 May;48(5):577-80. Japanese. PMID: 6234418.
Copy Download .nbib Format: NLM
Atazanavir nephrotoxicity.

Clinical kidney journal

Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M.
PMID: 25815168
Clin Kidney J. 2015 Apr;8(2):137-42. doi: 10.1093/ckj/sfv015. Epub 2015 Mar 20.

Atazanavir is commonly used as one of the key drugs in combination antiretroviral therapy for human immunodeficiency virus (HIV). However, atazanavir has the potential to yield its crystalline precipitation in urine and renal interstitial tissues, leading to crystalluria, urolithiasis,...

Cite
Hara M, Suganuma A, Yanagisawa N, et al. Atazanavir nephrotoxicity. Clin Kidney J. 2015;8(2):137-42doi: 10.1093/ckj/sfv015.
Hara, M., Suganuma, A., Yanagisawa, N., Imamura, A., Hishima, T., & Ando, M. (2015). Atazanavir nephrotoxicity. Clinical kidney journal, 8(2), 137-42. https://doi.org/10.1093/ckj/sfv015
Hara, Masaki, et al. "Atazanavir nephrotoxicity." Clinical kidney journal vol. 8,2 (2015): 137-42. doi: https://doi.org/10.1093/ckj/sfv015
Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M. Atazanavir nephrotoxicity. Clin Kidney J. 2015 Apr;8(2):137-42. doi: 10.1093/ckj/sfv015. Epub 2015 Mar 20. PMID: 25815168; PMCID: PMC4370314.
Copy Download .nbib Format: NLM
A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?.

Clinical journal of gastroenterology

Takao S, Tanaka K, Miyazaki M, Tanaka M, Ohashi T, Kato M, Kotoh K, Aishima S, Takayanagi R.
PMID: 26181836
Clin J Gastroenterol. 2013 Oct;6(5):386-9. doi: 10.1007/s12328-013-0406-x. Epub 2013 Jul 28.

Immunoglobulin light chain-associated (AL) amyloidosis is a multisystemic disorder characterized by extracellular deposition of immunoglobulin light chain produced by a proliferative plasma cell clone. Although the liver is the major organ involved in AL amyloidosis, hepatic involvement is often...

Cite
Takao S, Tanaka K, Miyazaki M, et al. A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?. Clin J Gastroenterol. 2013;6(5):386-9doi: 10.1007/s12328-013-0406-x.
Takao, S., Tanaka, K., Miyazaki, M., Tanaka, M., Ohashi, T., Kato, M., Kotoh, K., Aishima, S., & Takayanagi, R. (2013). A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?. Clinical journal of gastroenterology, 6(5), 386-9. https://doi.org/10.1007/s12328-013-0406-x
Takao, Shinichiro, et al. "A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?." Clinical journal of gastroenterology vol. 6,5 (2013): 386-9. doi: https://doi.org/10.1007/s12328-013-0406-x
Takao S, Tanaka K, Miyazaki M, Tanaka M, Ohashi T, Kato M, Kotoh K, Aishima S, Takayanagi R. A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?. Clin J Gastroenterol. 2013 Oct;6(5):386-9. doi: 10.1007/s12328-013-0406-x. Epub 2013 Jul 28. PMID: 26181836.
Copy Download .nbib Format: NLM
Mixed acinar-endocrine carcinoma of the pancreas treated with S-1.

Clinical journal of gastroenterology

Kanemasa Y, Kamisawa T, Tabata T, Kuruma S, Iwasaki S, Chiba K, Kuwata G, Fujiwara T, Egashira H, Koizumi K, Fujiwara J, Arakawa T, Momma K, Rokutan H, Horiguchi S, Hishima T.
PMID: 26182137
Clin J Gastroenterol. 2013 Dec;6(6):459-64. doi: 10.1007/s12328-013-0416-8. Epub 2013 Sep 05.

The case of a 63-year-old male with a large mass in the pancreatic tail and multiple liver metastases, diagnosed as acinar cell carcinoma of the pancreas with a few scattered endocrine cells by liver biopsy is presented. The S-1...

Cite
Kanemasa Y, Kamisawa T, Tabata T, et al. Mixed acinar-endocrine carcinoma of the pancreas treated with S-1. Clin J Gastroenterol. 2013;6(6):459-64doi: 10.1007/s12328-013-0416-8.
Kanemasa, Y., Kamisawa, T., Tabata, T., Kuruma, S., Iwasaki, S., Chiba, K., Kuwata, G., Fujiwara, T., Egashira, H., Koizumi, K., Fujiwara, J., Arakawa, T., Momma, K., Rokutan, H., Horiguchi, S., & Hishima, T. (2013). Mixed acinar-endocrine carcinoma of the pancreas treated with S-1. Clinical journal of gastroenterology, 6(6), 459-64. https://doi.org/10.1007/s12328-013-0416-8
Kanemasa, Yusuke, et al. "Mixed acinar-endocrine carcinoma of the pancreas treated with S-1." Clinical journal of gastroenterology vol. 6,6 (2013): 459-64. doi: https://doi.org/10.1007/s12328-013-0416-8
Kanemasa Y, Kamisawa T, Tabata T, Kuruma S, Iwasaki S, Chiba K, Kuwata G, Fujiwara T, Egashira H, Koizumi K, Fujiwara J, Arakawa T, Momma K, Rokutan H, Horiguchi S, Hishima T. Mixed acinar-endocrine carcinoma of the pancreas treated with S-1. Clin J Gastroenterol. 2013 Dec;6(6):459-64. doi: 10.1007/s12328-013-0416-8. Epub 2013 Sep 05. PMID: 26182137.
Copy Download .nbib Format: NLM
Longitudinal slit procedure in addition to negative pressure wound therapy for a refractory wound with exposed achilles tendon.

Eplasty

Ohata E, Yuzuriha S, Mishima Y, Matsuo K.
PMID: 25848445
Eplasty. 2015 Mar 18;15:e9. eCollection 2015.

OBJECTIVE: This case report reviews features of negative pressure wound therapy, particularly for the exposed Achilles tendon, and describes an additional effective procedure.METHODS: An 87-year-old man presented with a soft-tissue defect measuring 3×5 cm with the exposed Achilles tendon...

Cite
Ohata E, Yuzuriha S, Mishima Y, et al. Longitudinal slit procedure in addition to negative pressure wound therapy for a refractory wound with exposed achilles tendon. Eplasty. 2015;15:e9
Ohata, E., Yuzuriha, S., Mishima, Y., & Matsuo, K. (2015). Longitudinal slit procedure in addition to negative pressure wound therapy for a refractory wound with exposed achilles tendon. Eplasty, 15e9.
Ohata, Erika, et al. "Longitudinal slit procedure in addition to negative pressure wound therapy for a refractory wound with exposed achilles tendon." Eplasty vol. 15 (2015): e9.
Ohata E, Yuzuriha S, Mishima Y, Matsuo K. Longitudinal slit procedure in addition to negative pressure wound therapy for a refractory wound with exposed achilles tendon. Eplasty. 2015 Mar 18;15:e9. eCollection 2015. PMID: 25848445; PMCID: PMC4370208.
Copy Download .nbib Format: NLM
Rhodium-Catalyzed Atroposelective [2 + 2 + 2] Cycloaddition of Ortho-Substituted Phenyl Diynes with Nitriles: Effect of Ortho Substituents on Regio- and Enantioselectivity.

Organic letters

Kashima K, Teraoka K, Uekusa H, Shibata Y, Tanaka K.
PMID: 27074498
Org Lett. 2016 May 06;18(9):2170-3. doi: 10.1021/acs.orglett.6b00791. Epub 2016 Apr 13.

Axially chiral 3-(2-halophenyl)pyridines were successfully synthesized in high yields with excellent enantioselectivity by the cationic rhodium(I)/(S)-H8-BINAP complex-catalyzed atroposelective [2 + 2 + 2] cycloaddition of (o-halophenyl)diynes with nitriles. Interestingly, regio- and enantioselectivity highly depend on ortho substituents on the...

Cite
Kashima K, Teraoka K, Uekusa H, et al. Rhodium-Catalyzed Atroposelective [2 + 2 + 2] Cycloaddition of Ortho-Substituted Phenyl Diynes with Nitriles: Effect of Ortho Substituents on Regio- and Enantioselectivity. Org Lett. 2016;18(9):2170-3doi: 10.1021/acs.orglett.6b00791.
Kashima, K., Teraoka, K., Uekusa, H., Shibata, Y., & Tanaka, K. (2016). Rhodium-Catalyzed Atroposelective [2 + 2 + 2] Cycloaddition of Ortho-Substituted Phenyl Diynes with Nitriles: Effect of Ortho Substituents on Regio- and Enantioselectivity. Organic letters, 18(9), 2170-3. https://doi.org/10.1021/acs.orglett.6b00791
Kashima, Kenichi, et al. "Rhodium-Catalyzed Atroposelective [2 + 2 + 2] Cycloaddition of Ortho-Substituted Phenyl Diynes with Nitriles: Effect of Ortho Substituents on Regio- and Enantioselectivity." Organic letters vol. 18,9 (2016): 2170-3. doi: https://doi.org/10.1021/acs.orglett.6b00791
Kashima K, Teraoka K, Uekusa H, Shibata Y, Tanaka K. Rhodium-Catalyzed Atroposelective [2 + 2 + 2] Cycloaddition of Ortho-Substituted Phenyl Diynes with Nitriles: Effect of Ortho Substituents on Regio- and Enantioselectivity. Org Lett. 2016 May 06;18(9):2170-3. doi: 10.1021/acs.orglett.6b00791. Epub 2016 Apr 13. PMID: 27074498.
Copy Download .nbib Format: NLM
Mechanistic understanding of alkyne cyclotrimerization on mononuclear and dinuclear scaffolds: [4 + 2] cycloaddition of the third alkyne onto metallacyclopentadienes and dimetallacyclopentadienes.

Dalton transactions (Cambridge, England : 2003)

Yamamoto K, Nagae H, Tsurugi H, Mashima K.
PMID: 27730228
Dalton Trans. 2016 Nov 01;45(43):17072-17081. doi: 10.1039/c6dt03389j.

Cyclotrimerization of alkynes catalyzed by transition metal complexes is a straightforward synthetic method for constructing a benzene skeleton in organic synthesis. Not only mononuclear complexes, but also multinuclear complexes act as catalysts for alkyne cyclotrimerization, and their reaction mechanisms...

Cite
Yamamoto K, Nagae H, Tsurugi H, et al. Mechanistic understanding of alkyne cyclotrimerization on mononuclear and dinuclear scaffolds: [4 + 2] cycloaddition of the third alkyne onto metallacyclopentadienes and dimetallacyclopentadienes. Dalton Trans. 2016;45(43):17072-17081doi: 10.1039/c6dt03389j.
Yamamoto, K., Nagae, H., Tsurugi, H., & Mashima, K. (2016). Mechanistic understanding of alkyne cyclotrimerization on mononuclear and dinuclear scaffolds: [4 + 2] cycloaddition of the third alkyne onto metallacyclopentadienes and dimetallacyclopentadienes. Dalton transactions (Cambridge, England : 2003), 45(43), 17072-17081. https://doi.org/10.1039/c6dt03389j
Yamamoto, Keishi, et al. "Mechanistic understanding of alkyne cyclotrimerization on mononuclear and dinuclear scaffolds: [4 + 2] cycloaddition of the third alkyne onto metallacyclopentadienes and dimetallacyclopentadienes." Dalton transactions (Cambridge, England : 2003) vol. 45,43 (2016): 17072-17081. doi: https://doi.org/10.1039/c6dt03389j
Yamamoto K, Nagae H, Tsurugi H, Mashima K. Mechanistic understanding of alkyne cyclotrimerization on mononuclear and dinuclear scaffolds: [4 + 2] cycloaddition of the third alkyne onto metallacyclopentadienes and dimetallacyclopentadienes. Dalton Trans. 2016 Nov 01;45(43):17072-17081. doi: 10.1039/c6dt03389j. PMID: 27730228.
Copy Download .nbib Format: NLM
Plasmon resonance-enhanced circularly polarized luminescence of self-assembled meso-tetrakis(4-sulfonatophenyl)porphyrin-surfactant complexes in interaction with Ag nanoparticles.

Chemical communications (Cambridge, England)

Harada T, Kajiyama N, Ishizaka K, Toyofuku R, Izumi K, Umemura K, Imai Y, Taniguchi N, Mishima K.
PMID: 25111425
Chem Commun (Camb). 2014 Oct 04;50(76):11169-72. doi: 10.1039/c4cc04477k.

The chiroptical properties of an anionic meso-tetrakis(4-sulfonatophenyl)porphyrin (TPPS) complexed with cationic surfactants were enhanced by interaction with silver nanoparticles (AgNPs) in acidic solution. Improvement in chiroptical properties was revealed by circular dichroism (CD) and circularly polarized luminescence (CPL), with...

Cite
Harada T, Kajiyama N, Ishizaka K, et al. Plasmon resonance-enhanced circularly polarized luminescence of self-assembled meso-tetrakis(4-sulfonatophenyl)porphyrin-surfactant complexes in interaction with Ag nanoparticles. Chem Commun (Camb). 2014;50(76):11169-72doi: 10.1039/c4cc04477k.
Harada, T., Kajiyama, N., Ishizaka, K., Toyofuku, R., Izumi, K., Umemura, K., Imai, Y., Taniguchi, N., & Mishima, K. (2014). Plasmon resonance-enhanced circularly polarized luminescence of self-assembled meso-tetrakis(4-sulfonatophenyl)porphyrin-surfactant complexes in interaction with Ag nanoparticles. Chemical communications (Cambridge, England), 50(76), 11169-72. https://doi.org/10.1039/c4cc04477k
Harada, Takunori, et al. "Plasmon resonance-enhanced circularly polarized luminescence of self-assembled meso-tetrakis(4-sulfonatophenyl)porphyrin-surfactant complexes in interaction with Ag nanoparticles." Chemical communications (Cambridge, England) vol. 50,76 (2014): 11169-72. doi: https://doi.org/10.1039/c4cc04477k
Harada T, Kajiyama N, Ishizaka K, Toyofuku R, Izumi K, Umemura K, Imai Y, Taniguchi N, Mishima K. Plasmon resonance-enhanced circularly polarized luminescence of self-assembled meso-tetrakis(4-sulfonatophenyl)porphyrin-surfactant complexes in interaction with Ag nanoparticles. Chem Commun (Camb). 2014 Oct 04;50(76):11169-72. doi: 10.1039/c4cc04477k. PMID: 25111425.
Copy Download .nbib Format: NLM
Continuous Glucose Monitoring During Basal-Bolus Therapy Using Insulin Glargine 300 U mL(-1) and Glargine 100 U mL (-1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Jinnouchi H, Koyama M, Amano A, Takahashi Y, Yoshida A, Hieshima K, Sugiyama S, Kurinami N, Jinnouchi T, Becker R.
PMID: 26055218
Diabetes Ther. 2015 Jun;6(2):143-52. doi: 10.1007/s13300-015-0115-1. Epub 2015 Jun 09.

INTRODUCTION: New insulin glargine 300 U mL(-1) (Gla-300) is a basal insulin that shows more stable and prolonged pharmacokinetic and pharmacodynamic profiles than insulin glargine 100 U mL(-1) (Gla-100). This study used continuous glucose monitoring (CGM) to compare 24-h...

Cite
Jinnouchi H, Koyama M, Amano A, et al. Continuous Glucose Monitoring During Basal-Bolus Therapy Using Insulin Glargine 300 U mL(-1) and Glargine 100 U mL (-1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study. Diabetes Ther. 2015;6(2):143-52doi: 10.1007/s13300-015-0115-1.
Jinnouchi, H., Koyama, M., Amano, A., Takahashi, Y., Yoshida, A., Hieshima, K., Sugiyama, S., Kurinami, N., Jinnouchi, T., & Becker, R. (2015). Continuous Glucose Monitoring During Basal-Bolus Therapy Using Insulin Glargine 300 U mL(-1) and Glargine 100 U mL (-1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(2), 143-52. https://doi.org/10.1007/s13300-015-0115-1
Jinnouchi, Hideaki, et al. "Continuous Glucose Monitoring During Basal-Bolus Therapy Using Insulin Glargine 300 U mL(-1) and Glargine 100 U mL (-1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 6,2 (2015): 143-52. doi: https://doi.org/10.1007/s13300-015-0115-1
Jinnouchi H, Koyama M, Amano A, Takahashi Y, Yoshida A, Hieshima K, Sugiyama S, Kurinami N, Jinnouchi T, Becker R. Continuous Glucose Monitoring During Basal-Bolus Therapy Using Insulin Glargine 300 U mL(-1) and Glargine 100 U mL (-1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study. Diabetes Ther. 2015 Jun;6(2):143-52. doi: 10.1007/s13300-015-0115-1. Epub 2015 Jun 09. PMID: 26055218; PMCID: PMC4478173.
Copy Download .nbib Format: NLM
Hydrogenation of amides catalyzed by a combined catalytic system of a Ru complex with a zinc salt.

Chemical communications (Cambridge, England)

Kita Y, Higuchi T, Mashima K.
PMID: 25112156
Chem Commun (Camb). 2014 Oct 04;50(76):11211-3. doi: 10.1039/c4cc04481a.

Addition of catalytic amounts of zinc salts facilitated the hydrogenation of amides catalyzed by a ruthenium complex bearing 2-(diphenylphosphino)ethanamine (L1). The combined catalytic system of the ruthenium complex [RuCl2(L1)2] with a zinc salt such as Zn(OCOCF3)2 mediated hydrogenation of...

Cite
Kita Y, Higuchi T, Mashima K. Hydrogenation of amides catalyzed by a combined catalytic system of a Ru complex with a zinc salt. Chem Commun (Camb). 2014;50(76):11211-3doi: 10.1039/c4cc04481a.
Kita, Y., Higuchi, T., & Mashima, K. (2014). Hydrogenation of amides catalyzed by a combined catalytic system of a Ru complex with a zinc salt. Chemical communications (Cambridge, England), 50(76), 11211-3. https://doi.org/10.1039/c4cc04481a
Kita, Yusuke, et al. "Hydrogenation of amides catalyzed by a combined catalytic system of a Ru complex with a zinc salt." Chemical communications (Cambridge, England) vol. 50,76 (2014): 11211-3. doi: https://doi.org/10.1039/c4cc04481a
Kita Y, Higuchi T, Mashima K. Hydrogenation of amides catalyzed by a combined catalytic system of a Ru complex with a zinc salt. Chem Commun (Camb). 2014 Oct 04;50(76):11211-3. doi: 10.1039/c4cc04481a. PMID: 25112156.
Copy Download .nbib Format: NLM
Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)

Sato Y, Bernier F, Yamanaka Y, Aoshima K, Oda Y, Ingelsson M, Lannfelt L, Miyashita A, Kuwano R, Ikeuchi T.
PMID: 27239493
Alzheimers Dement (Amst). 2015 Mar 29;1(1):67-74. doi: 10.1016/j.dadm.2014.11.009. eCollection 2015 Mar.

BACKGROUND: We here examined whether plasma desmosterol-to-cholesterol ratio (DES/CHO) is decreased in patients with Alzheimer's disease (AD) and investigated the association between plasma DES/CHO and longitudinal cognitive decline.METHODS: Plasma DES/CHO of AD patients and age-matched controls in a Japanese...

Cite
Sato Y, Bernier F, Yamanaka Y, et al. Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease. Alzheimers Dement (Amst). 2015;1(1):67-74doi: 10.1016/j.dadm.2014.11.009.
Sato, Y., Bernier, F., Yamanaka, Y., Aoshima, K., Oda, Y., Ingelsson, M., Lannfelt, L., Miyashita, A., Kuwano, R., & Ikeuchi, T. (2015). Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 1(1), 67-74. https://doi.org/10.1016/j.dadm.2014.11.009
Sato, Yoshiaki, et al. "Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 1,1 (2015): 67-74. doi: https://doi.org/10.1016/j.dadm.2014.11.009
Sato Y, Bernier F, Yamanaka Y, Aoshima K, Oda Y, Ingelsson M, Lannfelt L, Miyashita A, Kuwano R, Ikeuchi T. Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease. Alzheimers Dement (Amst). 2015 Mar 29;1(1):67-74. doi: 10.1016/j.dadm.2014.11.009. eCollection 2015 Mar. PMID: 27239493; PMCID: PMC4876914.
Copy Download .nbib Format: NLM
Mixed-reality simulation for orthognathic surgery.

Maxillofacial plastic and reconstructive surgery

Fushima K, Kobayashi M.
PMID: 27014664
Maxillofac Plast Reconstr Surg. 2016 Mar 09;38(1):13. doi: 10.1186/s40902-016-0059-z. eCollection 2016 Dec.

BACKGROUND: Mandibular motion tracking system (ManMoS) has been developed for orthognathic surgery. This article aimed to introduce the ManMoS and to examine the accuracy of this system.METHODS: Skeletal and dental models are reconstructed in a virtual space from the...

Cite
Fushima K, Kobayashi M. Mixed-reality simulation for orthognathic surgery. Maxillofac Plast Reconstr Surg. 2016;38(1):13doi: 10.1186/s40902-016-0059-z.
Fushima, K., & Kobayashi, M. (2016). Mixed-reality simulation for orthognathic surgery. Maxillofacial plastic and reconstructive surgery, 38(1), 13. https://doi.org/10.1186/s40902-016-0059-z
Fushima, Kenji, and Kobayashi, Masaru. "Mixed-reality simulation for orthognathic surgery." Maxillofacial plastic and reconstructive surgery vol. 38,1 (2016): 13. doi: https://doi.org/10.1186/s40902-016-0059-z
Fushima K, Kobayashi M. Mixed-reality simulation for orthognathic surgery. Maxillofac Plast Reconstr Surg. 2016 Mar 09;38(1):13. doi: 10.1186/s40902-016-0059-z. eCollection 2016 Dec. PMID: 27014664; PMCID: PMC4783436.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 969 entries